← Back to Search

Community Resilience Program for Community Violence

N/A
Recruiting
Led By Elizabeth Miller, MD, PhD
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from 1 year period before baseline to approximately 2 years after baseline
Awards & highlights
No Placebo-Only Group

Summary

This trial tests a program where community members meet to discuss and plan ways to improve their neighborhood, focusing on safety and well-being for children and teens. The goal is to make people feel more connected and capable of reducing violence. The study involves neighborhoods in Pittsburgh and includes both youth and adults.

Who is the study for?
This trial is for youth (13 years and older) and adults of all genders who live in specific neighborhoods chosen for the study. It's not open to anyone younger than 13 or those living outside these neighborhoods.
What is being tested?
The study tests a community intervention called CRCEI aimed at increasing resilience and reducing violence, compared with standard health education sessions. Participants are grouped by neighborhood and randomly assigned to one of the interventions.
What are the potential side effects?
Since this trial involves community-based interventions rather than medical treatments, traditional side effects are not applicable. However, participants may experience changes in their perception of community safety or personal well-being.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from 1 year period before baseline to approximately 2 years after baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from 1 year period before baseline to approximately 2 years after baseline for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change from baseline in perceptions of neighborhood collective efficacy and community cohesion
Secondary study objectives
Change from baseline in collective efficacy and neighborhood social norms
Community incidence of violence in 12 month period
Number of self-reported events of violence exposure

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Community Resiliency Collective Efficacy Intervention (CRCEI)Experimental Treatment1 Intervention
Community Resiliency Collective Efficacy Intervention (CRCEI) to engage community members in dialogue on thriving, community leadership, and organizing for social change (9 sessions).
Group II: Health Education SessionsActive Control1 Intervention
Comparison neighborhoods will receive health education sessions as a control intervention. (9 sessions)

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Community-centered interventions aim to reduce physical violence by fostering a sense of community, promoting social cohesion, and building collective efficacy. These interventions work by empowering community members to support each other, address underlying social determinants of violence, and create a safer environment. Trauma-focused therapies, such as cognitive-behavioral therapy (CBT), help individuals process and heal from trauma, reducing the likelihood of violent behavior. Biochemical therapies may address underlying biochemical imbalances that contribute to aggressive behavior. These treatments are crucial for physical violence patients as they not only address immediate safety concerns but also promote long-term healing and resilience, reducing the risk of future violence.
Dropout from evidence-based trauma treatment in a community mental health clinic serving victims of interpersonal violence.Problem-Focused Psychodynamic Psychotherapies.The efficacy of complementary therapies for agitation among older people in residential care facilities: a systematic review.

Find a Location

Who is running the clinical trial?

University of PittsburghLead Sponsor
1,773 Previous Clinical Trials
16,348,030 Total Patients Enrolled
Centers for Disease Control and PreventionFED
885 Previous Clinical Trials
21,988,287 Total Patients Enrolled
Elizabeth Miller, MD, PhDPrincipal InvestigatorUniversity of Pittsburgh
8 Previous Clinical Trials
30,912 Total Patients Enrolled

Media Library

Community Resiliency Collective Efficacy Intervention (CRCEI) Clinical Trial Eligibility Overview. Trial Name: NCT05768217 — N/A
Physical Violence Research Study Groups: Community Resiliency Collective Efficacy Intervention (CRCEI), Health Education Sessions
Physical Violence Clinical Trial 2023: Community Resiliency Collective Efficacy Intervention (CRCEI) Highlights & Side Effects. Trial Name: NCT05768217 — N/A
Community Resiliency Collective Efficacy Intervention (CRCEI) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05768217 — N/A
~3067 spots leftby Sep 2026